Tag Archives: Pharmaceuticals

NewBridge Pharmaceuticals to Bring Novel Genomic Cancer Tests to Region

Science ArabBrains

NewBridge Pharmaceuticals, a specialty therapeutics company focused on pharmaceuticals,s, biologics, diagnostics and medical devices serving the AfMET markets (Africa, Middle East, Turkey and Caspian regions), today announced that it has entered into an exclusive agreement with Genomic Health, Inc. (NASDAQ: GHDX), a global health company that provides actionable genomic information to personalize genomic health decisions. Through this agreement, Genomic Health ...

Read More »

Biomed Analysis: Tackling drug-resistant malaria

Emerging resistance to artemisinin means efforts to track genetic markers and regulate the drug’s use must step up, says Priya Shetty. When parasites resistant to the anti-malarial drug artemisinin were discovered along the Thailand-Cambodia border in 2006, it sparked concern but not panic because it appeared to be an isolated pocket of resistance. Now, scientists have found multiple pockets of drug ...

Read More »

NGOs call for international regulation of synthetic biology

More than 100 non-governmental organisations (NGOs) have called for greater international oversight of the emerging science of synthetic biology – including a moratorium on the release and commercial use of synthetic organisms and their products until the potential risks are fully understood. Synthetic biology is a broad term covering new approaches to the development of biological functions and systems that ...

Read More »

Commitment to the MENA delivers results, with positive outlook for 2012

Hikma Pharmaceuticals PLC (LSE: HIK) (NASDAQ Dubai: HIK), the fast growing multinational pharmaceutical group, with sales in more than 40 countries across Europe, MENA and the USA, reports its preliminary results for the year ended 31 December 2011. Group revenue increased by 25.6% to $918.0 million, with organic growth of 7.6%, in line with the company’s guidance. Adjusted operating profit grew by ...

Read More »

Omnicell to exhibit at Dubai International conference and exhibition

Omnicell will Demonstrate Recently Introduced G4 Medication Automation Platform. Omnicell, Inc., OMCL +0.89% a leading global provider of medication and supply management solutions and analytics software for healthcare facilities, will exhibit its state-of-the-art G4 technology at the Dubai International Pharmaceuticals and Technologies Conference and Exhibition (DUPHAT) March 12-14 at the Dubai International Convention & Exhibition Centre. DUPHAT is one of the most recognized ...

Read More »

Nanotech offers more for health than nanodrugs

Nanotech in hygiene, fake drug detection and remote diagnosis will do more for health than nanodrugs, says Mohamed Abdel-Mottaleb. All countries should be planning for nanotechnology’s impact on healthcare, even if developing countries are involved in nanotechnology research mainly to find new treatments.

Read More »

Pharmaceuticals Sector

The Arab World’s healthcare sector needs to see considerable development in pharmaceuticals. The rapid growth of the pharmaceutical market in the region has presented the need to increase the quantity of production, and also increase the export ratio for quality products. Opportunities lie in the expansion of products, the search for new markets, and support for medical research. If you ...

Read More »

Healthcare Sector

The healthcare sector in The Arab World is showing signs of remarkable improvement as the quality of hospitals and the availability of qualified doctors has dramatically increased over the last few years. By making the transformation from traditional medicine to a modern and well structured system, many Arab countries have been able to meet their growing healthcare needs. If you ...

Read More »